09.06.22 -- Pediatric Dosage Forms: Reformulation And Development Expertise

Infrastructure and expertise cover the sweet spot for producing the small-to-midsize batches needed to meet industry demands for PDFs and orphan drugs, and also extend to large-scale manufacturing.

Electronic lab notebooks (ELNs) are one of the primary scientific informatics solutions for helping scientists design, execute, analyze and report on experiments — but selecting the right ELN can be a challenge.

Explore how you can simplify research on protein-protein interactions using our SPR systems.

A pharmaceutical company sought a development and manufacturing partner to assist with an in-licensed product originating from an emerging pharma company, a molecule in clinical Phase II / III trials.

Comprehensive diligence around a target before starting a discovery program can make the difference between success and failure.

In this webinar, our experts will discuss the latest advances of GI toxicity assessment empowered by stem cell and organ-on-a-chip technology.

The journey of a novel bioconjugate into the clinic is complex and uncertain. Explore the particular challenges when moving a bioconjugate candidate from early development into the clinic.

Dr. Friederike Hermann, head of occupational hygiene and biosafety, shares her expertise on bringing together multiple requirements and evaluating the right containment that meets the needs of all the process steps and stakeholders.